Ms. Melissa Freeman Emanuele, MA,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1550 Raydale Drive, Lousville, KY 40219 Phone: 502-968-6600 |
News Archive
Albireo today announced the completion of a phase 1b study showing a favorable tolerability and safety profile of A3309 in patients with chronic idiopathic constipation. In addition, the data revealed appropriate efficacy signals in this patient population. A3309 is a first in class compound developed for the treatment of chronic idiopathic constipation and constipation-predominant Irritable Bowel Syndrome (IBS-C).
Your wearable fitness tracker is great at counting the number of steps you took today, but it could also provide a new source of currency for the emerging health data economy, according to a new study in the journal Computer.
After identifying three different types of resistance to a promising investigational lung cancer drug in a phase 1 trial, a team of researchers led by Dana-Farber Cancer Institute scientists say new targeted inhibitors and combinations are urgently needed to stay ahead of tumors' constant and varied molecular shape-shifting.
Virtual Radiologic (vRad) and NightHawk Radiology today announced the completion of their previously announced merger, with NightHawk continuing as a wholly owned subsidiary of vRad. Under the terms of the merger agreement, vRad, a technology-enabled national radiology practice and leader in the development of radiologist workflow technology, acquired all of the outstanding shares of NightHawk for $6.50 per share in cash.
› Verified 2 days ago